![](https://france-biotech.fr/wp-content/uploads/2022/09/Logo-24-1024x1024.png)
![](https://france-biotech.fr/wp-content/uploads/2022/09/Logo-24-1024x1024.png)
![](https://france-biotech.fr/wp-content/uploads/2022/09/Logo-23-1024x1024.png)
POLYGON Therapeutics and Inserm Transfert sign a 18-month agreement for joint research in cardiovascular diseases
![](https://france-biotech.fr/wp-content/uploads/2022/09/Logo-22-1024x1024.png)
APMONIA THERAPEUTICS announces a 2.5€ million financing to develop its lead candidate targeting solid cancers
![](https://france-biotech.fr/wp-content/uploads/2022/09/Logo-21-1024x1024.png)
FineHeart annonce l’obtention de la certification ISO 13485 : 2016 – Systèmes de management de la qualité des dispositifs médicaux
![](https://france-biotech.fr/wp-content/uploads/2022/05/COAVEE-e1651648788950.jpg)
Coave Therapeutics Strengthens Leadership Team with the Appointments of Catherine Mathis as Vice President Regulatory Affairs and Julien Berger as Head of Legal Affairs
![](https://france-biotech.fr/wp-content/uploads/2022/03/IMMUTEP-BLANC.jpg)